[1]Ding BL, Li T, Wu ZhG. Research advances in growth factors to mobilize resident cardiac stem cells to repair myocardial injury[J].Guangdong Medical Journal, 2012, 33(6): 864-867. (in Chinese)
丁碧蓝,李涛,吴柱国. 生长因子动员原位心肌干细胞修复心肌损伤的研究进展[J]. 广东医学, 2012, 33(6): 864-867.
[2]Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart[J]. Circ Res, 2004, 95(9): 911-921.
[3]Fuentes T, Kearns-Jonker M. Endogenous cardiac stem cells for the treatment of heart failure[J]. Stem Cells Cloning. 2013, 6: 1-12.
[4]Linke A, Muller P,Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function[J]. Proc Natl Acad Sci USA, 2005, 102(25): 8966-8971.
[5]Chen W, Zhang L, Kong XZ, et al. Differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes induced by exogenous NKx2.5 gene[J]. Acta Anatomica Sinica, 2012, 43(4):484-489. (in Chinese)
陈炜,张雷,孔祥增,等.外源表达Nkx2.5诱导骨髓间充质干细胞向心肌分化[J].解剖学报, 2012, 43(4):484-489.
[6]Liu XCh, Zhu Y. Proliferative effect of insulin-like growth factor-1 on muscle-derived stem cells [J]. Acta Anatomica Sinica, 2008, 39(1):79-82. (in Chinese)
刘欣春,朱悦.胰岛素样生长因子-1对骨骼肌源性干细胞的促增殖效应[J].解剖学报, 2008,39(1):79-82.
[7]Ellison GM, Torella D, Dellegrottaglie S, et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart[J]. J Am Coll Cardiol, 2011, 58(9): 977-986.
[8]Badorff C, Brandes RP, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes[J]. Circulation, 2003, 107(7): 1024-1032.
[9]Christalla P, Hudson JE, Zimmermann WH. The cardiogenic niche as a fundamental building block of engineered myocardium[J]. Cells Tissues Organs, 2012, 195(1-2): 82-93.
[10]Feng Y, Yu XY, Wang Y. Recent concepts for the roles of progenitor/stem cell niche in heart repair[J]. Am J Cardiovasc Dis, 2012, 2(1): 75-83.
[11]Krankel N, Spinetti G, Amadesi S, et al. Targeting stem cell niches and trafficking for cardiovascular therapy[J]. Pharmacol Ther, 2011, 129(1): 62-81.
[12]Beitnes JO, Lunde K, Brinchmann JE, et al. Stem cells for cardiac repair in acute myocardial infarction[J]. Expert Rev Cardiovasc Ther, 2011, 9(8): 1015-1125.
[13]Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial[J]. Lancet, 2011, 378(9806): 1847-1857.
[14]HKh H, Mustafa A, Feng Y, et al. Genetic modification of stem cells for improved therapy of the infarcted myocardium[J]. Mol Pharm, 2011, 8(5): 1446-1457.
[15]Karantalis V, Balkan W, Schulman IH, et al. Cell-based therapy for prevention and reversal of myocardial remodeling[J]. Am J Physiol Heart Circ Physiol, 2012, 303(3): H256-270.
[16]Choi JS, Harley BA. The combined influence of substrate elasticity and ligand density on the viability and biophysical properties of hematopoietic stem and progenitor cells[J]. Biomaterials, 2012, 33(18): 4460-4468.
[17]Ou NW, Lu DF, Yang ZhJ, et al. Study on differentiation of murine cardiac stem cells cocultured with cardiomyocytes[J]. Chinese Journal of Thrombosis and Hemostasis, 2010, 2 (1):5-9. (in Chinese)
欧念文,陆东风,杨镇军,等.新生小鼠心肌干细胞与心肌细胞共培养诱导分化试验[J].血栓与止血学, 2010, 2 (1):5-9. |